Cabaletta Bio (CABA) News Today → The only AI company you should be looking at (From Behind the Markets) (Ad) Free CABA Stock Alerts $17.98 -0.76 (-4.06%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCabaletta Bio (NASDAQ:CABA) Shares Down 6.4% marketbeat.com - March 18 at 12:43 PMCabaletta Bio (CABA) to Release Quarterly Earnings on Thursdaymarketbeat.com - March 13 at 7:39 AMCabaletta Bio (NASDAQ:CABA) Trading Down 4.5%marketbeat.com - March 11 at 12:45 PMCabaletta Bio Set to Ignite Conversation at Upcoming Health Care Conferencesmsn.com - March 5 at 6:41 AMCabaletta Bio, Inc. (NASDAQ:CABA) Shares Purchased by Citigroup Inc.marketbeat.com - March 2 at 4:38 AMSwiss National Bank Invests $930,000 in Cabaletta Bio, Inc. (NASDAQ:CABA)marketbeat.com - March 1 at 4:04 AMCabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Rating of "Buy" from Analystsmarketbeat.com - February 28 at 1:19 AMSeveral Factors Led to the Outperformance of Cabaletta Bio (CABA) in Q4finance.yahoo.com - February 27 at 2:19 PMCabaletta Bio to Participate in Upcoming Investor Conferences in Marchglobenewswire.com - February 27 at 8:00 AMRafferty Asset Management LLC Takes $1.80 Million Position in Cabaletta Bio, Inc. (NASDAQ:CABA)marketbeat.com - February 23 at 5:47 AMCabaletta Bio Stock (NASDAQ:CABA) Dividends: History, Yield and Datesbenzinga.com - February 21 at 10:05 PMCabaletta Bio, Inc. (NASDAQ:CABA) Shares Purchased by Barclays PLCmarketbeat.com - February 21 at 4:13 AMCABA Mar 2024 35.000 callfinance.yahoo.com - February 17 at 1:12 PMCABA Mar 2024 30.000 callfinance.yahoo.com - February 17 at 8:12 AMCabaletta Bio (NASDAQ:CABA) Shares Gap Up to $22.03marketbeat.com - February 5 at 11:54 AMStrong Buy Rating for Cabaletta Bio Amid Positive CART Therapy Prospects and Market Potentialmarkets.businessinsider.com - February 5 at 8:43 AMCabaletta Bio (NASDAQ:CABA) Coverage Initiated at Jefferies Financial Groupmarketbeat.com - February 5 at 7:21 AMFDA Awards Orphan Drug Designation to Cabaletta's Innovative Myositis Therapymsn.com - February 3 at 7:08 AMCabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Recommendation of "Buy" from Brokeragesmarketbeat.com - February 3 at 1:23 AMCabaletta Bio (NASDAQ:CABA) Shares Up 6.1%marketbeat.com - February 2 at 1:59 PMCabaletta Bio CEO to Speak at Guggenheim's 6th Annual Biotech Conferencemsn.com - February 2 at 10:14 AMCabaletta Bio Gets Orphan Drug Designation for Potential Autoimmune Disease Treatmentmarketwatch.com - February 1 at 6:55 PMCabaletta Bio: Two Differentiated CAR-T Platforms To Carry It Forwardseekingalpha.com - January 31 at 9:41 AMCabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conferencefinance.yahoo.com - January 31 at 9:41 AMInsider Selling: Cabaletta Bio, Inc. (NASDAQ:CABA) Insider Sells 11,000 Shares of Stockmarketbeat.com - January 19 at 9:19 PMJennison Associates LLC Increases Holdings in Cabaletta Bio, Inc. (NASDAQ:CABA)marketbeat.com - January 18 at 6:37 AMAre Investors Undervaluing Cabaletta Bio, Inc. (NASDAQ:CABA) By 47%?finance.yahoo.com - January 9 at 7:40 AMCabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Rating of "Buy" from Brokeragesmarketbeat.com - January 9 at 2:19 AMCabaletta Bio gains on FDA fast-track tags for lead assetmsn.com - January 8 at 3:43 PMCabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201 in Dermatomyositis and Systemic Sclerosisfinance.yahoo.com - January 8 at 10:28 AMCabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 2 at 9:27 AMBarclays PLC Sells 62,102 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA)marketbeat.com - December 28 at 4:01 AMCabaletta Bio Inc Ordinary Sharesmorningstar.com - December 20 at 11:35 PMGwendolyn Binder Sells 11,000 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) Stockmarketbeat.com - December 19 at 9:33 PMCabaletta Bio Stock (NASDAQ:CABA): Analysts Expect More Gains Despite Massive Rallyfinance.yahoo.com - December 19 at 10:44 AMCabaletta Bio (CABA) Price Target Increased by 5.57% to 31.77msn.com - December 16 at 12:39 AMCabaletta Bio, Inc. (NASDAQ:CABA) Short Interest Up 12.1% in Novembermarketbeat.com - December 15 at 8:21 PMCabaletta Bio, Inc. (NASDAQ:CABA) Shares Purchased by Perceptive Advisors LLCmarketbeat.com - December 13 at 11:00 AMBain Capital Life Sciences Investors LLC Takes Position in Cabaletta Bio, Inc. (NASDAQ:CABA)marketbeat.com - December 11 at 8:47 AMCabaletta Bio: Expanding The Success Of CAR-T Beyond Oncologyseekingalpha.com - December 11 at 5:58 AMCabaletta Bio, Inc. (NASDAQ:CABA) Stake Lifted by Commodore Capital LPmarketbeat.com - December 10 at 11:01 AMBuy Cabaletta Bio's Promising SLE Treatmentseekingalpha.com - December 10 at 8:07 AMCabaletta Bio, Inc. (CABA)uk.finance.yahoo.com - November 28 at 5:41 PMCabaletta Bio Down as FDA Looks Into Issues With Several Companies' Approved CAR T Drugsmarketwatch.com - November 28 at 5:41 PMCabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapymsn.com - November 28 at 5:41 PMCabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx Conferencefinance.yahoo.com - November 28 at 5:41 PMCabaletta Bio (CABA) Price Target Increased by 8.76% to 30.09msn.com - November 27 at 9:39 PMCantor Fitzgerald Maintains Overweight Rating for Cabaletta Bio: Here's What You Need To Knowmarkets.businessinsider.com - November 15 at 3:19 PMAnalysts Offer Insights on Healthcare Companies: Vertex (VERX) and Cabaletta Bio (CABA)markets.businessinsider.com - November 10 at 11:06 AMLab Notes: Cabaletta Bio gets FDA nod to advance new drug; South Jersey firm raises $3.5Mbizjournals.com - November 10 at 11:06 AM Get Cabaletta Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for CABA and its competitors with MarketBeat's FREE daily newsletter. Email Address The only AI company you should be looking at (Ad)This is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse. Get the stock ticker here >>> CABA Media Mentions By Week CABA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CABA News Sentiment▼0.770.64▲Average Medical News Sentiment CABA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CABA Articles This Week▼42▲CABA Articles Average Week Get Cabaletta Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for CABA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HLVX News Today PRME News Today TRML News Today ALLO News Today RGNX News Today FATE News Today IMTX News Today CCCC News Today EXAI News Today TARS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CABA) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cabaletta Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.